ovarian cancer

Showing NaN - NaN of 107

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Ovarian Cancer Trial in Netherlands, United States (drug, device, procedure)

Completed
  • Ovarian Cancer
  • Phoenix, Arizona
  • +10 more
Jan 7, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

Effect of PARP Inhibitors on Glomerular Filtration Rate

Terminated
  • Solid Tumor
  • +2 more
  • Kidney Function Test
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 20, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L/Montanide ISA 51 VG, Ampligen,

Terminated
  • Ovarian Cancer
  • +2 more
  • OC-L/Montanide ISA 51 VG
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 18, 2021

Ovarian Cancer Trial in Worldwide (Prexasertib)

Completed
  • Ovarian Cancer
  • Tucson, Arizona
  • +45 more
Sep 28, 2021

Ovarian Cancer Trial in Worldwide (Olaparib, Ceralasertib, Placebo to match olaparib)

Withdrawn
  • Ovarian Cancer
  • Anchorage, Alaska
  • +25 more
Mar 9, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

Completed
  • Ovarian Cancer
  • +3 more
  • San Francisco, California
  • +15 more
Jan 19, 2021

Compare Fallopian Tube Cells Collected by Cytuity With Removed

Completed
  • Fallopian Tube Cancer
  • +10 more
  • Hysteroscopic cell sampling of the fallopian tube
  • San Diego, California
  • +9 more
Dec 30, 2020

Ovarian Cancer, Tumors, Carcinoma Trial in Philadelphia (enzastaurin)

Completed
  • Ovarian Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group 215-854-0770
Nov 24, 2020

Malignant Pleural Effusion, Lung Cancer, Mesothelioma Trial in Philadelphia (AdV-tk + valacyclovir)

Completed
  • Malignant Pleural Effusion
  • +4 more
  • AdV-tk + valacyclovir
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 2, 2020

Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +3 more
  • Mirvetuximab soravtansine
  • +3 more
  • Birmingham, Alabama
  • +130 more
Sep 24, 2020

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in United States (Paclitaxel, Carboplatin, Avastin)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Baltimore, Maryland
  • +4 more
Aug 17, 2020

Ovarian Cancer Trial in New York, Oklahoma City, Philadelphia (OMP-54F28, Paclitaxel and Carboplatin)

Completed
  • Ovarian Cancer
  • OMP-54F28, Paclitaxel and Carboplatin
  • New York, New York
  • +3 more
Aug 11, 2020

Ovarian Cancer Trial in Worldwide (carboplatin, paclitaxel, Avelumab)

Terminated
  • Ovarian Cancer
  • Alabaster, Alabama
  • +319 more
Jun 19, 2020

TeleGenetics Versus Usual Care To Increase Access To Cancer

Completed
  • Breast Cancer
  • +2 more
  • Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 3, 2020

Ovarian Cancer Trial in United States (CRLX101, Paclitaxel)

Terminated
  • Ovarian Cancer
  • Boston, Massachusetts
  • +6 more
May 26, 2020

Pelvic Floor Disorders in Survivors of Gynecologic Malignancies

Completed
  • Uterine Cancer
  • +5 more
  • Survey
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 28, 2020

Ovarian Cancer Trial in Philadelphia (Exercise)

Completed
  • Ovarian Cancer
  • Exercise
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 15, 2020

Ovarian Cancer, Pancreatic Cancer Trial in Philadelphia (Agent VM110 and laproscopic infra-red probe)

Terminated
  • Ovarian Cancer
  • Pancreatic Cancer
  • Agent VM110 and laproscopic infra-red probe
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 3, 2020

Physician-Patient Communication and Expectations Regarding

Terminated
  • Ovarian Cancer
  • Surveys
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 1, 2020

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (DC-Ova, DC Ova with Cyclophosphamide)

Completed
  • Ovarian Cancer
  • +2 more
  • DC-Ova
  • DC Ova with Cyclophosphamide
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 21, 2019

Ovarian Cancer Trial in Japan, United States (carboplatin, paclitaxel)

Completed
  • Ovarian Cancer
  • Birmingham, Alabama
  • +150 more
May 23, 2019

Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in United States (enzastaurin HCl)

Completed
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer
  • enzastaurin hydrochloride
  • Los Angeles, California
  • +15 more
Mar 8, 2019